Medical Devices

rhEPO Market in China 2016-2020

  • TEC612579
  • 65 Pages
  • June 2016
  • Medical Devices
About the Recombinant Human Erythropoietin (rhEPO) Market in China

Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein responsible for producing erythrocytes in the body. In the fetal stage, this protein is produced in the liver; it is secreted by the kidneys in adulthood. During anemic conditions, the body produces an excess of EPO, maintaining the inormal levels of red blood cells (RBC). When the endogenous production of EPO is disturbed because of diseases or the use of medications, the inormal RBC levels can be maintained by an external supply of EPO-stimulating agents (ESAs). These agents are similar to the inatural EPO in structure and function and are administered as injections. They can be produced by recombinant DNA technology and are used to treat anemia due to kidney diseases, cancer, HIV, injuries, or neural diseases.

Technavios analysts forecast the recombinant human erythropoietin (rhEPO) market in China to grow at a CAGR of 16.89% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the recombinant human erythropoietin (rhEPO) market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and biosimilars used for the treatment of anemia due to renal diseases, cancer chemotherapy, antiretroviral therapy, and wounds and neural diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on application of rhEPO:
End-stage renal disease (ESRD)
Cancer
Human immunodeficiency virus (HIV)
Wounds and neural disease

Technavio's report, Recombinant Human Erythropoietin (rhEPO) Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.

Key vendors
3S Bio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing

Other prominent vendors
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Huaxin High Biotechnology
Kehua Bio-Engineering
LG Life Sciences
Shenzhen Sai Bao Er Bio-Pharmaceutical
Sihuan
Shenyang Sunshine Pharmaceutical
Uni-Bio Science Group
Wanbang Biochemical Pharmaceuticals

Market driver
Increase in chronic kidney disease (CKD) and dialysis patient population
For a full, detailed list, view our report

Market challenge
Complex manufacturing process
For a full, detailed list, view our report

Market trend
Exploitation of novel therapeutic areas
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Medical Ultrasound Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Medical ultrasound devices use high frequency sound waves to visualize soft tissues such as tendons or internal organs. Ultrasound devices uses sound waves with frequencies that are higher than those ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Ablation Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Ablation is minimal invasion technique which involves removal of malfunctioning tissues either by surgery, chemicals or by radiofrequency. It is used in various treatments such as cancers, atrial fibrillation, cosmetology, ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Patient Monitoring Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Patient’s monitors include all kinds which are being used to track the vital signs of patients, in medical devices, used as monitoring devices, helps to communicate and integrate the information ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Transplant Diagnostics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Transplantation is the process of relocating organ in order to treat organ failure such as lungs, heart, pancreas, liver and kidney. Human leukocyte antigens (HLA) are the major histocompatibility complex ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Catheter Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Medical catheters are used in healthcare to deliver medications or to drain bodily fluids. They can be inserted into a body cavity, duct or blood vessel. Catheters play an important ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>